Withings Health Solutions and Babyscripts partner to combat leading cause of pregnancy-related mortality in the United States
Enabling real-time, remote patient monitoring (RPM) of hypertensive disorders of pregnancy (HDP)
Virtual maternity care program Babyscripts is to partner with digital healthtech provider Withings Health Solutions to strengthen its remote blood pressure monitoring capabilities.
Babyscripts will integrate Withings’ accessible, real-time monitoring devices in an effort to tackle a critical public health issue: hypertensive disorders of pregnancy (HDP). These disorders, including preeclampsia, impact nearly 15 percent of all pregnancies in the U.S. They are among the leading causes of maternal morbidity and mortality and are on the rise, with women having babies now twice as likely to develop HDP as their mothers.
Through this partnership, Babyscripts users will now have access to the Withings BPM Pro 2, an FDA-cleared cellular blood pressure monitor that supports convenient, at-home tracking.
BPM Pro 2’s first-of-its-kind feature, Patient Insights, prompts patients to answer a short questionnaire directly on the device screen after taking a reading to gather critical information around symptoms and risk factors. This allows healthcare providers to detect early warning signs of HDP outside of traditional clinical settings, enabling timely intervention - particularly for women in underserved or resource-limited communities.
“Hypertensive disorders of pregnancy develop silently but escalate quickly, which is why real-time home monitoring can be life-saving,” said Antoine Robiliard, Vice President of Withings Health Solutions.
“BPM Pro 2 and our Patient Insights feature were designed to go beyond the numbers, capturing symptoms and context from patients at the moment a high reading occurs. We are proud that Babyscripts has chosen Withings Health Solutions to support their proven maternity platform. Using BPM Pro 2, they’re delivering a solution that’s clinically robust, inclusive by design, and built for the realities of pregnancy, when ease, speed, and trust matter most.”
New guidance on personalized prenatal care
This announcement comes on the heels of new guidance from the American College of Obstetricians and Gynecologists (ACOG) which advocates for personalized prenatal care, such as routine monitoring of blood pressure and alternative care modalities like telemedicine to improve outcomes for pregnant and postpartum patients.
“Our decade of research and clinical implementation confirms that positive outcomes are linked to empowering women to monitor their own blood pressure and share data with providers,” said Anish Sebastian, CEO and co-founder of Babyscripts.
“Our partnership with Withings expands our reach and inclusivity by offering blood pressure cuffs that accommodate a broad range of body sizes and BMIs—ensuring accurate, equitable care for all patients.”
While many women may be educated about recognizable symptoms of HDP - such as persistent headaches or swelling - issues can often present without visible symptoms, making proactive monitoring essential for early detection and critical intervention. This was the case for Meredith Jones (name changed) whose healthy pregnancy took a sudden, life-threatening turn at 38 weeks when she recorded several elevated blood pressure readings. Equipped with a Withings blood pressure cuff and education from Babyscripts, Meredith recognized the warning signs of preeclampsia and sought immediate care. She was admitted to the hospital and induced, ultimately delivering a healthy baby boy.
Remote patient monitoring (RPM) with devices like those from Withings Health Solutions provides a practical, scalable way for providers and patients to manage hypertensive disorders of pregnancy (HDP).
By combining this technology with Babyscripts’ virtual maternity care platform, the two companies are setting a new standard for maternal health - delivering evidence-based solutions that reduce risk and save lives.